STAT+: Covid-19 burnished pharma’s reputation among patient groups, but access to medicines is now an issue
More than half of patient groups surveyed in a new report say pharma isn't doing enough to provide access to medicines around the world.
In the wake of the Covid-19 pandemic, the pharmaceutical industry enjoyed something of an afterglow, as far as patient advocacy groups were concerned.
Not anymore.
What's Your Reaction?
